Eight more ways to deal with antibiotic resistance

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 8, 2014, Pages 4253-4256

  Metz, Matthew ^a,c   Shlaes, David M ^b  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b Anti Infectives Consulting   (United States)

^c DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL HUSBANDRY; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL (TOPIC); ECONOMICS; ETHICS; GOVERNMENT; HUMAN; INFORMATION DISSEMINATION; LEGISLATION AND JURISPRUDENCE; ORGANIZATION AND MANAGEMENT; QUALITY CONTROL; SYNTHESIS; UNITED STATES;

ANIMAL HUSBANDRY; ANIMALS; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE, MICROBIAL; HUMANS; INFORMATION DISSEMINATION; PRIVATE SECTOR; QUALITY CONTROL; UNITED STATES; UNITED STATES GOVERNMENT AGENCIES;

EID: 84905397156     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02623-14     Document Type: Review

References (26)

1. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA. www.cdc.gov/ drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf.
2. Bartlett JG, Spellberg B, Gilbert DN. 7 August 2013. 8 ways to deal with antibiotic resistance. WebMD LLC, New York, NY. www.medscape.com/viewarticle/ 808814.
3. Committee for Medicinal Products for Human Use (CHMP). 2013. Addendum to the guideline on the evaluation of medicinal products indicated for treatment of bacterial infections. Document EMA/CHMP/351889/2013. European Medicines Agency, London, United Kingdom. http://www.ema.europa.eu/docs/en-GB/document-library/ Scientific-guideline/2013/11/WC500153953.pdf. Accessed 3 May 2014.
4. US Department of Agriculture. 14 February 2006. Grading, certification and verification-AMS grading services. Agricultural Marketing Service, US Department of Agriculture, Washington, DC. http://www.ams.usda.gov/AMSv1.0/ grading. Accessed 5 June 2014.
5. US Department of Agriculture. 30 April 2014. National Organic Program. Agricultural Marketing Service, US Department of Agriculture. http://www.ams.usda.gov/AMSv1.0/nop. Accessed 5 June 2014.
6. US Department of Agriculture. May 2013. BioPreferred-BioPreferred Program, US Department of Agriculture. http://www.biopreferred.gov/files/BP- Fact-Sheet-HR.pdf. Accessed 5 June 2014.
7. American Academy of Microbiology. 2009. Antibiotic resistance: an ecological perspective on an old problem. American Society for Microbiology, Washington, DC. http://academy.asm.org/index.php/environmental-microbiology- ecology-evolution/473-antibiotic-resistance-an-ecological-perspective-on-an-old- problem. Accessed 10 May 2014.
8. US Environmental Protection Agency. 27 June 2012. Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). US Environmental Protection Agency, Washington, DC. www.epa.gov/agriculture/lfra.html. Accessed 5 June 2014.
9. Pew Charitable Trusts, Campaign on Human Health and Industrial Farming. 2014. Antibiotic resistance and food animal production: a bibliography of scientific studies (1969-2014). The Pew Charitable Trusts, Philadelphia, PA. http://www.pewhealth.org/reports-analysis/issue-briefs/bibliography-on- antibiotic-resistance-and-food-animal-production-85 899368032.
10. Forsberg KJ, Reyes A, Wang B, Selleck EM, Sommer MO, Dantas G. 2012. The shared antibiotic resistome of soil bacteria and human pathogens. Science 337:1107-1111. http://dx.doi.org/10.1126/science.1220761.
11. Kluytmans JA, Overdevest IT, Willemsen I, Kluytmans-van Den Bergh MF, Van Der Zwaluw K, Heck M, Rijnsburger M, Vandenbroucke-Grauls CM, Savelkoul PH, Johnston BD, Gordon D, Johnson JR. 2013. Extended-spectrum ß-lactamase- producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin. Infect. Dis. 56:478-487. http://dx.doi.org/10.1093/cid/cis929.
12. Harrison EM, Paterson GK, Holden MT, Larsen J, Stegger M, Larsen AR, Petersen A, Skov RL, Christensen JM, Bak Zeuthen A, Heltberg O, Harris SR, Zadoks RN, Parkhill J, Peacock SJ, Holmes MA. 2013. Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC. EMBO Mol. Med. 5:509-515. http://dx.doi.org/10.1002/emmm.201202413.
13. Mather AE, Reid SW, Maskell DJ, Parkhill J, Fookes MC, Harris SR, Brown DJ, Coia JE, Mulvey MR, Gilmour MW, Petrovska L, De Pinna E, Kuroda M, Akiba M, Izumiya H, Connor TR, Suchard MA, Lemey P, Mellor DJ, Haydon DT, Thomson NR. 2013. Distinguishable epidemics of multidrug-resistant Salmonella typhimurium dt104 in different hosts. Science 341:1514-1517. http://dx.doi.org/10.1126/ science.1240578.
14. U. S. Food and Drug Administration. 2014. FDA update on animal pharmaceutical industry response to guidance # 213, March 26. U. S. Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/AnimalV eterinary/SafetyHealth/AntimicrobialResistance/JudiciousUseofAntimicrobials/ ucm390738.htm. Accessed 10 May 2014.
15. Federal Register. 2014. New animal drugs for use in animal feeds; withdrawal of approval of new animal drug applications; bambermycins; hygromycin B; lincomycin; pyrantel; tylosin; tylosin and sulfamethazine; virginiamycin: a rule by the Food and Drug Administration on 04/10/2014. Fed. Regist. 79:19814-19815. https://www.federalregister.gov/articles/2014/04/10/2014-08011/ new-animal-drugs-for-use-in-animal-feeds-withdrawal-of-approval-of-new-animal- drug-applications.
16. U. S. Food and Drug Administration. 2013. Guidance for industry no. 213. New animal drugs and new animal drug combination products administered in or on medicated feed or drinking water of food-producing animals: recommendations for drug sponsors for voluntarily aligning product use conditions with GFI no. 209. Center for Veterinary Medicine, Food and Drug Administration, U. S. Department of Health and Human Services, Rockville, MD. www.fda.gov/downloads/ AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM299624. pdf. Accessed 10 May 2014.
17. Nikaido H. 2009. Multidrug resistance in bacteria. Annu. Rev. Biochem. 78:119-146. http://dx.doi.org/10.1146/annurev. biochem.78.082907.145923.
18. Centers for Disease Control and Prevention. 29 August 2013. Antibiotic/Antimicrobial Resistance-Interagency Task Force on Antimicrobial Resistance. Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA. www.cdc.gov/drugresistance/actionplan/ taskforce.html. Accessed 5 June 2014.
19. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054. http://dx.doi.org/10.1128/AAC.00774-09.
20. U. S. Food and Drug Administration. 2 April 2014. Drugs-Bioequivalence recommendations for specific products. Food and Drug Administration, U. S. Department of Health and Human Services, Washington, DC. http://www.fda.gov/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075207.htm. Accessed 5 June 2014.
21. U. S. Food and Drug Administration. 8 November 2013. FDA takes action to speed safety information updates on generic drugs. Food and Drug Administration, U. S. Department of Health and Human Services, Washington, DC. http://www.fda.gov/NewsEvents/Newsroom/Press Announcements/ucm374171.htm. Accessed 5 June 2014.
22. U. S. Food and Drug Administration. 17 October 2013. Anti-Infective Drugs Advisory Committee meeting announcement. Food and Drug Administration, US Department of Health and Human Services, Washington, DC. http://www.fda.gov/ AdvisoryCommittees/Calendar/ucm364149.htm. Accessed 5 June 2014.
23. Roberts RR, Hota B, Ahmad I, Scott RD, Jr, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. 2009. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin. Infect. Dis. 49:1175-1184. http://dx.doi.org/10.1086/605630.
24. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS. 2003. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 36:592-598. http://dx.doi.org/10. 1086/367653.
25. Mossialos E, Morel C, Edwards S, Berenson J, Gemmill-Toyama M, Brogan D. 2009. Policies and incentives for promoting innovation in antibiotic research. The London School of Economics and Political Science, London, United Kingdom. http://www.lse.ac.uk/LSEHealthAnd SocialCare/impacts/Antibiotics%20Report.aspx.
26. Pew Charitable Trusts Antibiotics and Innovation Project. 2013. A new pathway for antibiotic innovation: exploring drug development for limited populations. The Pew Charitable Trusts, Philadelphia, PA. http://www.pewhealth. org/other-resource/a-new-pathway-for-antibiotic-innovation-exploring-drug- development-for-limited-populations-85899450008.